Literature DB >> 19158392

Fine tuning the cell cycle: activation of the Cdk1 inhibitory phosphorylation pathway during mitotic exit.

Tamara A Potapova1, John R Daum, Kendra S Byrd, Gary J Gorbsky.   

Abstract

Inactivation of cyclin-dependent kinase (Cdk) 1 promotes exit from mitosis and establishes G1. Proteolysis of cyclin B is the major known mechanism that turns off Cdk1 during mitotic exit. Here, we show that mitotic exit also activates pathways that catalyze inhibitory phosphorylation of Cdk1, a mechanism previously known to repress Cdk1 only during S and G2 phases of the cell cycle. We present evidence that down-regulation of Cdk1 activates Wee1 and Myt1 kinases and inhibits Cdc25 phosphatase during the M to G1 transition. If cyclin B/Cdk1 complex is present in G1, the inhibitory sites on Cdk1 become phosphorylated. Exit from mitosis induced by chemical Cdk inhibition can be reversed if cyclin B is preserved. However, this reversibility decreases with time after mitotic exit despite the continued presence of the cyclin. We show that this G1 block is due to phosphorylation of Cdk1 on inhibitory residues T14 and Y15. Chemical inhibition of Wee1 and Myt1 or expression of Cdk1 phosphorylation site mutants allows reversal to M phase even from late G1. This late Cdk1 reactivation often results in caspase-dependent cell death. Thus, in G1, the Cdk inhibitory phosphorylation pathway is functional and can lock Cdk1 in the inactive state.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158392      PMCID: PMC2655249          DOI: 10.1091/mbc.e08-07-0771

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  39 in total

1.  Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.

Authors:  I Vincent; G Jicha; M Rosado; D W Dickson
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

Review 2.  Living with or without cyclins and cyclin-dependent kinases.

Authors:  Charles J Sherr; James M Roberts
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

3.  Systems-level dissection of the cell-cycle oscillator: bypassing positive feedback produces damped oscillations.

Authors:  Joseph R Pomerening; Sun Young Kim; James E Ferrell
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

4.  Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins.

Authors:  Aiyang Cheng; Wen Xiong; James E Ferrell; Mark J Solomon
Journal:  Cell Cycle       Date:  2005-01-05       Impact factor: 4.534

Review 5.  CDK activation by non-cyclin proteins.

Authors:  Angel R Nebreda
Journal:  Curr Opin Cell Biol       Date:  2006-02-17       Impact factor: 8.382

6.  Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways.

Authors:  Nobumoto Watanabe; Harumi Arai; Jun-Ichi Iwasaki; Masaaki Shiina; Kazuhiro Ogata; Tony Hunter; Hiroyuki Osada
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

7.  Temporal and spatial control of cyclin B1 destruction in metaphase.

Authors:  P Clute; J Pines
Journal:  Nat Cell Biol       Date:  1999-06       Impact factor: 28.824

8.  The reversibility of mitotic exit in vertebrate cells.

Authors:  Tamara A Potapova; John R Daum; Bradley D Pittman; Joanna R Hudson; Tara N Jones; David L Satinover; P Todd Stukenberg; Gary J Gorbsky
Journal:  Nature       Date:  2006-04-13       Impact factor: 49.962

Review 9.  The when and wheres of CDC25 phosphatases.

Authors:  Rose Boutros; Christine Dozier; Bernard Ducommun
Journal:  Curr Opin Cell Biol       Date:  2006-02-17       Impact factor: 8.382

10.  Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line.

Authors:  Osamu Hashimoto; Masako Shinkawa; Takuji Torimura; Toru Nakamura; Karuppaiyah Selvendiran; Masaharu Sakamoto; Hironori Koga; Takato Ueno; Michio Sata
Journal:  BMC Cancer       Date:  2006-12-19       Impact factor: 4.430

View more
  44 in total

1.  JLK1486, a Bis 8-Hydroxyquinoline-Substituted Benzylamine, Displays Cytostatic Effects in Experimental Gliomas through MyT1 and STAT1 Activation and, to a Lesser Extent, PPARγ Activation.

Authors:  Céline Bruyère; Sébastien Madonna; Gwendoline Van Goietsenoven; Véronique Mathieu; Jean Dessolin; Jean-Louis Kraus; Florence Lefranc; Robert Kiss
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

2.  Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance.

Authors:  Andrew Burgess; Suzanne Vigneron; Estelle Brioudes; Jean-Claude Labbé; Thierry Lorca; Anna Castro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-10       Impact factor: 11.205

3.  Regulated activity of PP2A-B55 delta is crucial for controlling entry into and exit from mitosis in Xenopus egg extracts.

Authors:  Satoru Mochida; Satoshi Ikeo; Julian Gannon; Tim Hunt
Journal:  EMBO J       Date:  2009-08-20       Impact factor: 11.598

Review 4.  Phosphatases: providing safe passage through mitotic exit.

Authors:  Claudia Wurzenberger; Daniel W Gerlich
Journal:  Nat Rev Mol Cell Biol       Date:  2011-07-13       Impact factor: 94.444

Review 5.  Regulated protein kinases and phosphatases in cell cycle decisions.

Authors:  Bela Novak; Orsolya Kapuy; Maria Rosa Domingo-Sananes; John J Tyson
Journal:  Curr Opin Cell Biol       Date:  2010-08-02       Impact factor: 8.382

6.  Chk1 and Wee1 kinases coordinate DNA replication, chromosome condensation, and anaphase entry.

Authors:  Barbara Fasulo; Carol Koyama; Kristina R Yu; Ellen M Homola; Tao S Hsieh; Shelagh D Campbell; William Sullivan
Journal:  Mol Biol Cell       Date:  2012-01-19       Impact factor: 4.138

Review 7.  Critical reanalysis of the methods that discriminate the activity of CDK2 from CDK1.

Authors:  Nandini Sakurikar; Alan Eastman
Journal:  Cell Cycle       Date:  2016-03-17       Impact factor: 4.534

8.  Dual phosphorylation of cdk1 coordinates cell proliferation with key developmental processes in Drosophila.

Authors:  Joseph O Ayeni; Ramya Varadarajan; Oindrila Mukherjee; David T Stuart; Frank Sprenger; Martin Srayko; Shelagh D Campbell
Journal:  Genetics       Date:  2013-11-08       Impact factor: 4.562

9.  Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.

Authors:  Marguerite L Palisoul; Jeanne M Quinn; Emily Schepers; Ian S Hagemann; Lei Guo; Kelsey Reger; Andrea R Hagemann; Carolyn K McCourt; Premal H Thaker; Matthew A Powell; David G Mutch; Katherine C Fuh
Journal:  Mol Cancer Ther       Date:  2017-09-13       Impact factor: 6.261

10.  A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity.

Authors:  Anne Margriet Heijink; Vincent A Blomen; Xavier Bisteau; Fabian Degener; Felipe Yu Matsushita; Philipp Kaldis; Floris Foijer; Marcel A T M van Vugt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.